Who owns Sorrento Therapeutics?
- Ticker: SRNEQ
- CUSIP Number: 83587f202
Tip: Access positions for across all investors
Analyze quarterly positions in Sorrento Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sorrento Therapeutics stock
Who bought or sold Sorrento Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lattice Capital Management | 52k | $6.4k | 100% | Dec 2023 |
|
| Kitzinger Lautmann Capital Management | 30k | $3.7k | 50% | Dec 2023 |
|
| HighPoint Advisor | 22k | $0 | 100% | Dec 2023 |
|
| SlateStone Wealth | 21k | $3.0k | -31% | Dec 2023 |
|
| Huntington National Bank | 5.0k | $619.123800 | -67% | Dec 2023 |
|
| Ogorek Anthony Joseph | 3.6k | $0 | 0% | Dec 2023 |
|
| AlphaMark Advisors | 2.1k | $0 | 0% | Mar 2024 |
|
| Highlander Capital Management | 1.2k | $147.960000 | 0% | Dec 2023 |
|
| Trust Co Of Vermont | 204.00 | $24.990000 | 0% | Dec 2023 |
|
Who sold out of Sorrento Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Russell Investments | Sep 2023 | 266.00 | $25.004000 |